Understanding the molecular intricacies involved during Simian Immunodeficiency Virus (SIV) genomic RNA packaging
Year: 2025
Type: article
Abstract: Simian immunodeficiency virus (SIV) is a lentivirus that serves as an important non-human primate model to study HIV replication, and pathogenesis of human AIDS, while also holding promise as a vector for human gene therapy.This study aimed to understand the molecular intricacies involved during the packaging of SIV genomic RNA (gRNA) into the nascently forming virions.In particular, we investigated the role of single-stranded purines (ssPurines) during SIV gRNA packaging.Similar ssPurines have been implicated as important motifs for gRNA packaging in many retroviruses like HIV-1, MPMV, and MMTV by serving as Gag precursor polypeptide binding sites during virion assembly.In the SHAPE-validated secondary structure of the SIV 5' leader sequences we identified four stretches of ssPurines (named I-IV) in the region that harbors major packaging determinants of SIV gRNA packaging.Employing a combination of genetic and biologically relevant single round of replication assay we established that while ssPurine II is essential, the other stretches of ssPurines (I, III, & IV) do not significantly contribute towards SIV gRNA packaging.Structure prediction analysis of these mutants corroborated strongly with the biological data and revealed that the unpaired nature of ssPurine II is critical for its function during SIV RNA packaging perhaps by functioning as a specific binding site for SIV precursor polypeptide Pr55 Gag during SIV replication.The SIV precursor polypeptide Pr55 Gag drives viral assembly and facilitates specific recognition and packaging of the SIV gRNA into viral particles.While several studies have tried to elucidate the role of SIV Pr55 Gag by expressing its different components independently, studies using full-length SIV Pr55 Gag have not been conducted, primarily due to the unavailability of purified and biologically active full-length SIV Pr55 Gag .Therefore, we addressed a longstanding challenge in SIV research regarding the expression and purification of full-length SIV precursor polypeptide Pr55 Gag .We overcame this obstacle by sub-optimally expressing the soluble form of full-length SIV Pr55 Gag in bacteria, which we purified using affinity and gel filtration chromatography techniques.The purified Pr55 Gag demonstrated its biological functionality by assembling it into virus-like particles (VLPs) in vitro.In vivo experiments also confirmed formation of functional VLPs which were observed to be competent for efficiently packaging of SIV gRNA.The methodological advancement presented here vi ensures the availability of highly pure, biologically active full-length SIV Pr55 Gag , facilitating future studies elucidating protein structure and RNA-protein interactions crucial during SIV gRNA packaging.
Author: Pillai Vineeta Narayana
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Funder: Pécsi Tudományegyetem
OpenAlex ID: W7137576029
